This inventor holds 1 USPTO granted patent and 2 published patent applications and 2 EPO patents. Top assignee: Other. Active years: 2021.
Company Filing History:
1 out of 834,453 Years Active: 2021
Title: Michele Maio: Innovator in Cancer Therapy
Introduction
Michele Maio is a prominent inventor based in Roveredo in Piano, Italy. He has made significant contributions to the field of cancer therapy through his innovative research and development of DNA hypomethylating agents. His work aims to improve treatment options for cancer patients, showcasing his dedication to advancing medical science.
Latest Patents
Michele Maio holds a patent for a method of treating and/or preventing cancer. This invention involves administering a combination of an effective amount of a DNA hypomethylating agent along with at least one immunomodulatory agent and/or an optional targeted therapy agent. This groundbreaking approach has the potential to enhance the efficacy of cancer treatments.
Career Highlights
Throughout his career, Michele Maio has focused on the intersection of molecular biology and oncology. His research has led to advancements in understanding how DNA hypomethylation can influence cancer progression and treatment responses. His dedication to innovation in this field has earned him recognition among his peers.
Collaborations
Michele has collaborated with notable colleagues, including Sandra Coral and Alessia Covre. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the impact of their research.
Conclusion
Michele Maio's contributions to cancer therapy through his innovative patent demonstrate his commitment to improving patient outcomes. His work exemplifies the importance of research and collaboration in the fight against cancer.